Recurrent meningioma treated with boron neutron capture therapy: a feasibility study with dosimetric and clinical correlates.

J Neurooncol · 2025 · PMC12420710 · PMID 40745077

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Tumor location influenced dosimetry; non–skull base tumors received higher doses and showed a trend toward better response.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.